155. ランドウ・クレフナー症候群 Acquired aphasia with convulsive disorder Clinical trials / Disease details
臨床試験数 : 1 / 薬物数 : 2 - (DrugBank : 2) / 標的遺伝子数 : 29 - 標的パスウェイ数 : 14
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02904265 (ClinicalTrials.gov) | September 2016 | 13/9/2016 | Efficacy Study of Acetazolamide Versus Diazepam in Continuous Spike and Wave/Landau-Kleffner Syndrome | Non-inferiority Prospective Randomized Trial of Acetazolamide Versus Diazepam in Patients With Continuous Spike and Wave in Sleep (CSWS)/Landau Kleffner Syndrome (LKS) | Landau-Kleffner Syndrome;Status Epilepticus, Electrographic | Drug: Diazepam;Drug: Acetazolamide | Mayo Clinic | NULL | Terminated | 3 Years | 12 Years | All | 3 | Phase 2/Phase 3 | United States |